Biosynthesis of heme in mammals

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1763, Issue 7, 2006, Pages 723-736

  Ajioka, Richard S ^a   Phillips, John D ^a   Kushner, James P ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Heme; Iron; Porphyrias; Porphyrin

Indexed keywords

ACETIC ACID; BETA CAROTENE; COLESTYRAMINE; CYTOCHROME; FERROCHELATASE; HEMATIN; HEME; HEMOGLOBIN; HEMOPROTEIN; IRON; MACROCYCLIC COMPOUND; PROPIONIC ACID; PROTOPORPHYRIN; PYRROLE; TETRAPYRROLE DERIVATIVE; TRANSCRIPTION FACTOR;

BIOCHEMISTRY; BIOSYNTHESIS; CRYSTAL STRUCTURE; ENZYME MECHANISM; ERYTHROID CELL; ERYTHROPOIETIC PROTOPORPHYRIA; GENE; GENE MUTATION; HUMAN; MAMMAL; MITOCHONDRION; MOLECULAR CLONING; NONHUMAN; OINTMENT; PORPHYRIA; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; REVIEW; X LINKED SIDEROBLASTIC ANEMIA;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; FERROCHELATASE; HEME; MAMMALS; MODELS, MOLECULAR; PROTEIN CONFORMATION;

MAMMALIA;

EID: 33746927585     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2006.05.005     Document Type: Review

References (107)

1. Wessling-Resnick M. Iron transport. Annu. Rev. Nutr. 20 (2000) 129-151
2. Anderson K.E., et al. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver C.R., et al. (Ed). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, NY 2991-3062
3. Cotter P.D., et al. Assignment of human erythroid delta-aminolevulinate synthase (ALAS2) to a distal subregion of band Xp11.21 by PCR analysis of somatic cell hybrids containing X; autosome translocations. Genomics 13 1 (1992) 211-212
4. Cox T.C., et al. Erythroid 5-aminolevulinate synthase is located on the X chromosome. Am. J. Hum. Genet. 46 1 (1990) 107-111
5. Astner I., et al. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO J. 24 18 (2005) 3166-3177
6. Lathrop J.T., and Timko M.P. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. Science 259 5094 (1993) 522-525
7. Munakata H., et al. Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. J. Biochem. (Tokyo) 136 2 (2004) 233-238
8. Dailey T.A., Woodruff J.H., and Dailey H.A. Examination of mitochondrial protein targeting of haem synthetic enzymes: in vivo identification of three functional haem-responsive motifs in 5-aminolaevulinate synthase. Biochem. J. 386 Pt. 2 (2005) 381-386
9. Roberts A.G., and Elder G.H. Alternative splicing and tissue-specific transcription of human and rodent ubiquitous 5-aminolevulinate synthase (ALAS1) genes. Biochim. Biophys. Acta 1518 1-2 (2001) 95-105
10. Srivastava G., et al. Regulation of 5-aminolevulinate synthase mRNA in different rat tissues. J. Biol. Chem. 263 11 (1988) 5202-5209
11. Surinya K.H., Cox T.C., and May B.K. Transcriptional regulation of the human erythroid 5-aminolevulinate synthase gene. Identification of promoter elements and role of regulatory proteins. J. Biol. Chem. 272 42 (1997) 26585-26594
12. Cable E.E., Miller T.G., and Isom H.C. Regulation of heme metabolism in rat hepatocytes and hepatocyte cell lines: delta-aminolevulinic acid synthase and heme oxygenase are regulated by different heme-dependent mechanisms. Arch. Biochem. Biophys. 384 2 (2000) 280-295
13. Roberts A.G., Redding S.J., and Llewellyn D.H. An alternatively-spliced exon in the 5′-UTR of human ALAS1 mRNA inhibits translation and renders it resistant to haem-mediated decay. FEBS Lett. 579 5 (2005) 1061-1066
14. Handschin C., et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 122 4 (2005) 505-515
15. Wu Z., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 1 (1999) 115-124
16. Virbasius J.V., and Scarpulla R.C. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc. Natl. Acad. Sci. U. S. A. 91 4 (1994) 1309-1313
17. Scassa M.E., et al. Hepatic nuclear factor 3 and nuclear factor 1 regulate 5-aminolevulinate synthase gene expression and are involved in insulin repression. J. Biol. Chem. 279 27 (2004) 28082-28092
18. Scassa M.E., et al. Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin. Exp. Cell Res. 271 2 (2001) 201-213
19. Anderson K.E., et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann. Intern. Med. 142 6 (2005) 439-450
20. Phillips J.D., and Kushner J.P. Fast track to the porphyrias. Nat. Med. 11 10 (2005) 1049-1050
21. Wingert R.A., et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 436 7053 (2005) 1035-1039
22. Napier I., Ponka P., and Richardson D.R. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105 5 (2005) 1867-1874 %R 10.1182/blood-2004-10-3856
23. Rouault T.A., and Tong W.-H. Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat. Rev., Mol. Cell Biol. 6 4 (2005) 345
24. Fleming M.D. The genetics of inherited sideroblastic anemias. Semin. Hematol. 39 4 (2002) 270-281
25. Harris J.W., et al. Pyridoxine responsive anemia in the human adult. Proc. Soc. Exp. Biol. Med. 91 3 (1956) 427-432
26. Erskine P.T., et al. X-ray structure of 5-aminolevulinic acid dehydratase from Escherichia coli complexed with the inhibitor levulinic acid at 2.0 A resolution. Biochemistry 38 14 (1999) 4266-4276
27. Frankenberg N., et al. High resolution crystal structure of a Mg2+-dependent porphobilinogen synthase. J. Mol. Biol. 289 3 (1999) 591-602
28. Anderson P.M., and Desnick R.J. Purification and properties of delta-aminolevulinate dehydrase from human erythrocytes. J. Biol. Chem. 254 15 (1979) 6924-6930
29. Bevan D.R., Bodlaender P., and Shemin D. Mechanism of porphobilinogen synthase. Requirement of Zn2+ for enzyme activity. J. Biol. Chem. 255 5 (1980) 2030-2035
30. Dent A.J., et al. Two different zinc sites in bovine 5-aminolevulinate dehydratase distinguished by extended X-ray absorption fine structure. Biochemistry 29 34 (1990) 7822-7828
31. Jaffe E.K., et al. 5-Chlorolevulinate modification of porphobilinogen synthase identifies a potential role for the catalytic zinc. Biochemistry 31 7 (1992) 2113-2123
32. Potluri V.R., et al. Human delta-aminolevulinate dehydratase: chromosomal localization to 9q34 by in situ hybridization. Hum. Genet. 76 3 (1987) 236-239
33. Kaya A.H., et al. Human delta-aminolevulinate dehydratase (ALAD) gene: structure and alternative splicing of the erythroid and housekeeping mRNAs. Genomics 19 2 (1994) 242-248
34. Mitchell G.A., et al. Hypertyrosinemia. In: Scriver C.R., et al. (Ed). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, N.Y. 1777-1806
35. Sassa S., and Kappas A. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone. J. Clin. Invest. 71 3 (1983) 625-634
36. Thunell S., et al. Liver transplantation in a boy with acute porphyria due to aminolaevulinate dehydratase deficiency. Eur. J. Clin. Chem. Clin. Biochem. 30 10 (1992) 599-606
37. Astrin K.H., et al. delta-Aminolevulinic acid dehydratase isozymes and lead toxicity. Ann. N. Y. Acad. Sci. 514 (1987) 23-29
38. Helliwell J.R., et al. Time-resolved and static-ensemble structural chemistry of hydroxymethylbilane synthase. Faraday Discuss 122 (2003) 131-144 (discussion 171-190)
39. Shoolingin-Jordan P.M., et al. Human porphobilinogen deaminase mutations in the investigation of the mechanism of dipyrromethane cofactor assembly and tetrapyrrole formation. Biochem. Soc. Trans. 31 Pt. 3 (2003) 731-735
40. Wang A.L., et al. Regional gene assignment of human porphobilinogen deaminase and esterase A4 to chromosome 11q23 leads to 11qter. Proc. Natl. Acad. Sci. U. S. A. 78 9 (1981) 5734-5738
41. Mignotte V., et al. Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proc. Natl. Acad. Sci. U. S. A. 86 17 (1989) 6548-6552
42. Chretien S., et al. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc. Natl. Acad. Sci. U. S. A. 85 1 (1988) 6-10
43. Grandchamp B., et al. Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene. Eur. J. Biochem. 162 1 (1987) 105-110
44. Badminton M.N., and Elder G.H. Molecular mechanisms of dominant expression in porphyria. J. Inherit. Metab. Dis. 28 3 (2005) 277-286
45. Nordmann Y., et al. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. J. Intern. Med. 242 3 (1997) 213-217
46. Soonawalla Z.F., et al. Liver transplantation as a cure for acute intermittent porphyria. Lancet 363 9410 (2004) 705-706
47. Mathews M.A., et al. Crystal structure of human uroporphyrinogen III synthase. EMBO J. 20 21 (2001) 5832-5839
48. Aizencang G., et al. Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression. Genomics 70 2 (2000) 223-231
49. Astrin K.H., et al. Regional assignment of the human uroporphyrinogen III synthase (UROS) gene to chromosome 10q25.2-q26.3. Hum. Genet. 87 1 (1991) 18-22
50. Aizencang G.I., et al. Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene. J. Biol. Chem. 275 4 (2000) 2295-22304
51. Desnick R.J., and Astrin K.H. Congenital erythropoietic porphyria: advances in pathogenesis and treatment. Br. J. Haematol. 117 4 (2002) 779-795
52. Desnick R.J., et al. Molecular genetics of congenital erythropoietic porphyria. Semin. Liver Dis. 18 1 (1998) 77-84
53. Phillips J.D., et al. Congenital erythropoietic porphyria, b-thalassemia intermedia and thrombocytopenia due to a GATA1 mutation. Blood 106 (2005) 154a
54. Straka J.G., and Kushner J.P. Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase. Biochemistry 22 20 (1983) 4664-4672
55. Smith A.G., and Francis J.E. Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase. Biochem. J. 183 2 (1979) 455-458
56. Whitby F.G. Crystal structure of human uroporphyrinogen decarboxylase. EMBO J. 17 9 (1998) 2463-2471
57. Phillips J.D., et al. Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase. EMBO J. 22 23 (2003) 6225-6233
58. de Verneuil H., et al. Assignment of the gene for uroporphyrinogen decarboxylase to human chromosome 1 by somatic cell hybridization and specific enzyme immunoassay. Hum. Genet. 66 2-3 (1984) 202-205
59. Dubart A., et al. Assignment of human uroporphyrinogen decarboxylase (URO-D) to the p34 band of chromosome 1. Hum. Genet. 73 3 (1986) 277-279
60. Romana M., et al. Structure of the gene for human uroporphyrinogen decarboxylase. Nucleic Acids Res. 15 18 (1987) 7343-7356
61. Romeo P.H., Raich N., Dubart A., Beaupain D., Pryor M., Kushner J., Cohen-Solal M., and Goosens M. Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. J. Biol. Chem. 261 (1986) 9825-9831
62. Elder G.H. Genetic defects in the porphyrias: types and significance. Clin. Dermatol. 16 2 (1998) 225-233
63. Elder G.H., and Worwood M. Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload. Hepatology 27 1 (1998) 289-291
64. Franklin M.R., Phillips J.D., and Kushner J.P. Uroporphyria in the uroporphyrinogen decarboxylase-deficient mouse: interplay with siderosis and polychlorinated biphenyl exposure. Hepatology 36 4 Pt. 1 (2002) 805-811
65. Franklin M.R., Phillips J.D., and Kushner J.P. Accelerated development of uroporphyria in mice heterozygous for a deletion at the uroporphyrinogen decarboxylase locus. J. Biochem. Mol. Toxicol. 15 5 (2001) 287-293
66. Phillips J.D., et al. A mouse model of familial porphyria cutanea tarda. Proc. Natl. Acad. Sci. U. S. A. 98 1 (2001) 259-264
67. Garey J.R., et al. Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. Gastroenterology 105 1 (1993) 165-169
68. Felsher B.F., and Kushner J.P. Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect. Semin. Hematol. 14 2 (1977) 243-251
69. Bulaj Z.J., et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 95 5 (2000) 1565-1571
70. Yoshinaga T., and Sano S. Coproporphyrinogen oxidase: II. Reaction mechanism and role of tyrosine residues on the activity. J. Biol. Chem. 255 10 (1980) 4727-4731
71. Lee D.S., et al. Structural basis of hereditary coproporphyria. Proc. Natl. Acad. Sci. U. S. A. 102 40 (2005) 14232-14237
72. Taketani S., et al. Involvement of peripheral-type benzodiazepine receptors in the intracellular transport of heme and porphyrins. J. Biochem. (Tokyo) 117 4 (1995) 875-880
73. Martasek P., et al. Human coproporphyrinogen oxidase. Biochemical characterization of recombinant normal and R231W mutated enzymes expressed in E. coli as soluble, catalytically active homodimers. Cell Mol. Biol. (Noisy-le-grand) 43 1 (1997) 47-58
74. Phillips J.D., et al. Crystal structure of the oxygen-dependant coproporphyrinogen oxidase (Hem13p) of Saccharomyces cerevisiae. J. Biol. Chem. 279 37 (2004) 38960-38968
75. Cacheux V., et al. Localization of the human coproporphyrinogen oxidase gene to chromosome band 3q12. Hum. Genet. 94 5 (1994) 557-559
76. Takahashi S., et al. Differential regulation of coproporphyrinogen oxidase gene between erythroid and nonerythroid cells. Blood 92 9 (1998) 3436-3444
77. Takahashi S., et al. Cloning of a coproporphyrinogen oxidase promoter regulatory element binding protein. Biochem. Biophys. Res. Commun. 273 2 (2000) 596-602
78. Lamoril J., et al. A molecular defect in coproporphyrinogen oxidase gene causing harderoporphyria, a variant form of hereditary coproporphyria. Hum. Mol. Genet. 4 2 (1995) 275-278
79. Martasek P., Nordmann Y., and Grandchamp B. Homozygous hereditary coproporphyria caused by an arginine to tryptophane substitution in coproporphyrinogen oxidase and common intragenic polymorphisms. Hum. Mol. Genet. 3 3 (1994) 477-480
80. Koch M., et al. Crystal structure of protoporphyrinogen IX oxidase: a key enzyme in haem and chlorophyll biosynthesis. EMBO J. 23 8 (2004) 1720-1728
81. Morgan R.R., Errington R., and Elder G.H. Identification of sequences required for the import of human protoporphyrinogen oxidase to mitochondria. Biochem. J. 377 Pt. 2 (2004) 281-287
82. Roberts A.G., et al. Partial characterization and assignment of the gene for protoporphyrinogen oxidase and variegate porphyria to human chromosome 1q23. Hum. Mol. Genet. 4 12 (1995) 2387-2390
83. Taketani S., et al. The human protoporphyrinogen oxidase gene (PPOX): organization and location to chromosome 1. Genomics 29 3 (1995) 698-703
84. Taketani S., et al. Induction of terminal enzymes for heme biosynthesis during differentiation of mouse erythroleukemia cells. Eur. J. Biochem. 230 2 (1995) 760-765
85. Whatley S.D., et al. Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. Am. J. Hum. Genet. 65 4 (1999) 984-994
86. Meissner P.N., et al. A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat. Genet. 13 1 (1996) 95-97
87. Frank J., et al. Homozygous variegate porphyria: identification of mutations on both alleles of the protoporphyrinogen oxidase gene in a severely affected proband. J. Invest. Dermatol. 110 4 (1998) 452-455
88. Roberts A.G., et al. Molecular characterization of homozygous variegate porphyria. Hum. Mol. Genet. 7 12 (1998) 1921-1925
89. Stojeba N., et al. Recovery from a variegate porphyria by a liver transplantation. Liver Transpl. 10 7 (2004) 935-938
90. Meissner P., Adams P., and Kirsch R. Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria. J. Clin. Invest. 91 4 (1993) 1436-1444
91. Wu C.K., et al. The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis. Nat. Struct. Biol. 8 2 (2001) 156-160
92. Proulx K.L., Woodard S.I., and Dailey H.A. In situ conversion of coproporphyrinogen to heme by murine mitochondria: terminal steps of the heme biosynthetic pathway. Protein Sci. 2 7 (1993) 1092-1098
93. Burden A.E., et al. Human ferrochelatase: crystallization, characterization of the [2Fe-2S] cluster and determination that the enzyme is a homodimer. Biochim. Biophys. Acta 1435 1-2 (1999) 191-197
94. Whitcombe D.M., et al. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22. Genomics 11 4 (1991) 1152-1154
95. Taketani S., et al. Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18. Eur. J. Biochem. 205 1 (1992) 217-222
96. Tugores A., Magness S.T., and Brenner D.A. A single promoter directs both housekeeping and erythroid preferential expression of the human ferrochelatase gene. J. Biol. Chem. 269 49 (1994) 30789-30797
97. Magness S.T., et al. Analysis of the human ferrochelatase promoter in transgenic mice. Blood 92 1 (1998) 320-328
98. Karr S.R., and Dailey H.A. The synthesis of murine ferrochelatase in vitro and in vivo. Biochem. J. 254 3 (1988) 799-803
99. Taketani S., Adachi Y., and Nakahashi Y. Regulation of the expression of human ferrochelatase by intracellular iron levels. Eur. J. Biochem. 267 15 (2000) 4685-4692
100. Liu Y.L., et al. Regulation of ferrochelatase gene expression by hypoxia. Life Sci. 75 17 (2004) 2035-2043
101. Went L.N., and Klasen E.C. Genetic aspects of erythropoietic protoporphyria. Ann. Hum. Genet. 48 Pt. 2 (1984) 105-117
102. Gouya L., et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am. J. Hum. Genet. 58 2 (1996) 292-299
103. Gouya L., et al. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood 93 6 (1999) 2105-2110
104. Bloomer J.R. The liver in protoporphyria. Hepatology 8 2 (1988) 402-407
105. McGuire B.M., et al. Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl. 11 12 (2005) 1590-1596
106. Poh-Fitzpatrick M.B., et al. Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations. J. Am. Acad. Dermatol. 46 6 (2002) 861-866
107. Goodwin R.G., et al. Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells. Blood 107 1 (2006) 60-62